The new UK Life Sciences Vision sets out a mission-led approach with bold ambition for the next decade to ensure scientific excellence, following the UK's life sciences sector's central role in the country's efforts to combat COVID-19 with the Oxford-AstraZeneca vaccine made in Thames Valley's Oxfordshire.
The Vision outlines 7 critical healthcare missions that government, industry, the NHS, academia and medical research charities will work together on at speed to solve – from cancer treatment to tackling dementia.
The missions are:
Accelerating the pace of studies into novel dementia treatment
Enabling early diagnosis and treatments, including immune therapies such as cancer vaccines
Sustaining the UK’s position in vaccine discovery, development and manufacturing
Treatment and prevention of cardiovascular diseases and its major risk factors, including obesity
Reducing mortality and morbidity from respiratory disease in the UK and globally
Addressing the underlying biology of ageing
Increasing the understanding of mental health conditions, including work to redefine diseases and develop tools to address them